Ghent, Belgium -- A universal influenza vaccine that has been pioneered by researchers from VIB and Ghent University is being tested for the first time on humans by the British-American biotech company Acambis. This vaccine is intended to provide protection against all ??strains of the virus that causes human influenza, including pandemic strains.
